de novo design in the synthetically accessible compounds universe

webinar

Tue, 23 Feb 2016, 16:00 CET (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

de novo design in the synthetically accessible compounds universe

No matter how big your in-house library and no matter how many compounds you acquire as supplement, it merely scratches the surface of what chemists are capable of synthesizing. Recent publications indicate that the majority of chemical space is defined on the basis of only 50-70 robust chemical reactions. We have used these to compile a Chemical Space comprising billions of virtual compounds with high likelihood of straight forward synthetic access. We make this literature-derived collection publicly available and also provide a unique similarity search method capable to explore such wealth of data. Imagine de novo design of (a) hit expansion libraries, (b) follow-up series and (c) fragment evolution designs from within an all accessible compound space. We will demonstrate how this can become reality.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on